- ►duanessolution.com PC Issa, RP Finger, FG Holz, HPN Scholl - British Journal of Ophthalmology, 2008 - bjo.bmj.com Results: Mean follow-up time was 18 months (range 16–21 months). The mean VA
at four selected time points (1 month after second treatment, 1 month and 3–4
months after last treatment, and at last visit) increased significantly (by ... Cited by 7 - Related articles - All 5 versions
J Ruys, JJ De Laey, Y Vanderhaeghen, EH … - Eye, 2007 - nature.com Jump to main content; Jump to navigation; nature.com homepage; Publications AZ index;
Browse by subject. My account; Submit manuscript; Register; Subscribe; RCOphth ... Cited by 4 - Related articles - BL Direct - All 3 versions
[CITATION] Intravitreal bevacizumab for the treatment of type 2 idiopathic macular telangiectasis
F Rensch, UH Spandau, F Schlichtenbrede, S … - Ophthalmic surgery, lasers & imaging: the official … - ncbi.nlm.nih.gov BACKGROUND AND OBJECTIVE: To evaluate the effect of intravitreal bevacizumab on
visual acuity in patients with myopic choroidal neovascularization. PATIENTS AND
METHODS: The retrospective case series study included 13 patients with ... Cited by 5 - Related articles - BL Direct - All 3 versions
P Charbel Issa, HM Helb, FG Holz, HPN … - American Journal of Ophthalmology, 2008 - Elsevier Mean central retinal thickness was reduced compared with that of normal eyes.
There was no significant correlation between central foveal thickness and foveal
light sensitivity or visual acuity, respectively. Also, there was no ... Cited by 5 - Related articles - All 2 versions
SJ Moon, AS Berger, MJ Tolentino, DM Misch - Ophthalmic surgery, lasers & imaging: the official … - ncbi.nlm.nih.gov To assess the potential visual benefit of intravitreal bevacizumab in a patient
with idiopathic juxtafoveal retinal telangiectasis refractory to focal laser
treatment, an intravitreal injection of bevacizumab (1.25 mg) was given. ... Cited by 8 - Related articles - BL Direct - All 3 versions
D Karagiannis, I Georgalas, I Ladas, P … - Clinical Interventions in Aging, 2009 - pubmedcentral.nih.gov A 65-year-old lady presented with decreased vision in her left eye (LE). Best
corrected visual acuity (BCVA) was 1/20. Complete examination showed idiopathic
juxtafoveal retinal telangiectasis associated with subretinal ... Related articles - All 6 versions
- ►duanessolution.com [PDF] PC Issa, FG Holz, HPN Scholl, G Bonn - Retina, 2009 - duanessolution.com 1. In 1968, Gass published a series of landmark articles describing fluorescein
angiography stud- ies of macular dysfunction secondary to retinal vascular
disease. One of these articles is referred to several times in the ... Related articles - View as HTML
FK Chen, PJ Patel, W Xing, C Bunce, C Egan, … - Investigative Ophthalmology & Visual Science, 2009 - ARVO METHODS. In this prospective study, 50 patients were enrolled with a range of
macular diseases. One examiner performed two consecutive microperimetry tests
for all patients using the same test strategy. Test–retest variability ... Related articles - All 5 versions
H Nomoto, F Shiraga, N Kuno, E Kimura, S … - Investigative Ophthalmology & Visual Science, 2009 - ARVO RESULTS. After intravitreal injection in the treated eye, the mean maximum
concentrations (C max ) of bevacizumab in the iris/ciliary body and
retina/choroid were 109,192.6, and 93,990.0 ng/g, respectively, whereas ... Related articles - All 3 versions
